Australia HospeTrack Hospital Intelligence Report 2022: Upcoming Developments in Cancer Care Infrastructure to Drive Demand in Australia's Medical Device Industry - ResearchAndMarkets.com
23 Nov 2022
Radiation Therapy
DUBLIN--(BUSINESS WIRE)--The "HospeTrack Hospital Intelligence for Australia" report has been added to ResearchAndMarkets.com's offering.
Upcoming developments in cancer care infrastructure to drive demand in Australian medical device industry.
The report provides account-level directional detail on total beds, ICU beds, ORs, ventilators, incubators, and other medical equipment installed in Australia as well as Anesthesia Machines, Dialysis machines, C-Arms, Cath Labs, PET, SPECT, CT, MRI scanners, Ultrasound, and X-Ray machines, Mammography machines, DEXA and LINAC making it the most nuanced source of hospital-level intelligence for Australia's medical equipment installed base.
As of 2021-22, Australia has 655 public healthcare facilities and 1,317 private facilities including imaging centers. The country has one of the best healthcare systems in the world, contributing to an average life expectancy of 83 years. Public healthcare is funded by the Australian government through tax revenues.
Along with that, national health subsidy schemes such as Medicare covers both public, and private hospital facilities. However, inequitable access to services has caused declining health outcomes in rural areas as compared to larger urban locales. Furthermore, a rise in incidence of chronic diseases is being observed countrywide over the past few years. Australia has the highest number of cancer cases in the world, with an estimated 150,000 cases of cancer diagnosed each year.
In addition to the existing med-tech market, development of new medical technologies and devices is plausible in the next decade. For example, the Medical Research Future Fund has financed $5 billion for about 20 initiatives harnessing med-tech and pharmaceutical innovation, providing vital infrastructure, improving patient outcomes, and generating jobs and economic growth.
Advancements are also being made in the field of digital health to improve management of diabetes and chronic diseases, remote patient monitoring, mental health, diagnosis and screenings, and clinical decision support.
According to this HospeTrack Hospital Intelligence for Australia, nuclear medicine and molecular imaging market is likely to present pockets of growth opportunities primarily related to the increasing prevalence of cancer. Each year, an average of 3.3% escalation in cases may possibly be observed in the country, with over 170,000 new cancer cases being potentially diagnosed by 2024. To curb the current disease burden, over 560,000 nuclear medicine procedures are performed every year in the country.
As per HospeTrack, there are about 80+ PET scanners, and 70+ SPECT scanners throughout Australia. With respect to the healthcare workforce, there are approximately 450 qualified nuclear medicine specialists that provide nuclear medicine services in nearly 200 locations across the country. Collaborations by research universities and national organizations are underway for the procurement of new PET/CT scanners as well as replacement of existing units in the country.
Contents:
1. Visualize and Map the Total Installed Base of the Country by Hospital
Monitoring & Access: ECG Machines, Holter monitors, Patient monitors, Ventilators, Anesthesia machines, Stress Testing Machines
Surgical: C-Arms
Cardio: Echocardiography, Cath Labs
Diagnostic Imaging: PET-CT,PET-MRI, SPECT, CT Scanners, MRI Scanners, Ultrasound, X-Ray Machines, Mammography machines, DEXA
Infant Care: Incubators, Radiant Warmers, Fetal monitors, Phototherapy Units, Infant Ventilators
Renal: Dialysis Machine
Radiation Therapy: LINAC, Cobalt-60
Hospital IT: PACS, EMR
2. Generate Targeted Leads Based on Current Care Area Focus of a Hospital
13 care areas tracked for each hospital
General Medicine, Gyn/Obs, Neurology, Internal Medicine, ER/Trauma, Pulmonology, GI, Cardiology, Oncology, Radiology, Nephrology, Ortho and Nuclear Medicine included in the report
3. Visualize the Current Health Resource Status of a Hospital
Total number of doctors by hospital
Total number of Radiologists by hospital
Total number of Cardiologists by hospital
Total number of internal medicine physicians by hospital
Surgeons, neurosurgeons and orthopedic surgeons by hospital
4. Comprehend Medical Services Potential Using Bed and Operating Rooms Data
Total bed size of a hospital
Number of ICU beds by hospital
Number of NICU, PICU beds by hospital
Number of Major and Minor Operating Rooms available per hospital
Total number of outpatient visits per hospital where available
Total number of inpatient visits per hospital where available
5. Understand and Identify Types of Hospitals
Hospitals by ownership type - public and private
Assess and differentiate based on size of hospital - University hospitals, State hospitals, Private hospitals and Imaging centers
Chart and map based on level of care - Secondary and tertiary care
6. Create Opportunity Heat Maps
655 hospitals and Imaging centers in Australia listed by city, region, latitude and longitude and Zip Code
Contact numbers available for 95% of the hospitals
Website links mentioned for hospital where available
7. Estimate Market Potential of Equipment in the Country
Companies Mentioned
Drager
Fresinius
Gambro
Nipro
Canon Medical
Shimadzu
Hologic
Elekta
For more information about this report visit https://www.researchandmarkets.com/r/jaqj6e
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.